454 Life Sciences and its marketing partner, Roche Applied Science, announced last week that they had launched 454's new DNA sequencer, the first of a new wave of competing sequencing technologies expected to hit the market over the next year.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.
The New York Times reports on the shifting interpretations of what some genetic variants mean over time.
In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.
MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.